Tackling Polycystic Ovary Syndrome
 January 2001   
in “
 Drug and therapeutics bulletin 
”
 
    polycystic ovary syndrome  PCOS  hirsutism  male-pattern baldness  acne  irregular menstrual cycles  obesity  elevated testosterone  elevated luteinising hormone  insulin resistance  abnormal serum lipid levels  diabetes mellitus  PCOS  male-pattern baldness  acne  irregular periods  obesity  high testosterone  high LH  insulin resistance  high cholesterol  diabetes   
    
   TLDR  The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.   
  The document from January 1, 2001, discusses the prevalence and characteristics of polycystic ovary syndrome (PCOS) in the UK, where up to one-third of women have polycystic ovaries, and approximately one-third of these women exhibit PCOS. PCOS is typically defined by the presence of polycystic ovaries along with symptoms such as hirsutism, male-pattern baldness, acne, irregular menstrual cycles, obesity, and elevated levels of testosterone and/or luteinising hormone. The review also highlights the associated metabolic issues with PCOS, including insulin resistance and abnormal serum lipid levels, which increase the risk of diabetes mellitus in affected women. The document aims to review the management strategies for women with PCOS.
   